To date, magnetic resonance imaging (MRI) for measuring brain volume and neuronal connections, and Aβ- or tau-based positron-emission tomography (PET) for detecting pathological protein deposition in the brain have been used in AD diagnosis [10–13]. The gene discussed is MAPT; the disease is Alzheimer disease.